U.S. manufacturers are sharply increasing production of cheap, fast – but less accurate – Covid-19 tests, aiming for 100 million per month by year-end 2020 that will enable schools and workplaces to significantly expand testing.
https://www.pharmalive.com/wp-content/uploads/2020/09/Trump-administration-sending-rapid-Covid-tests-to-states-CDC-bars-evictions-Reuters-9-1-20.jpeg7331100Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2020-09-17 17:21:422020-09-17 22:30:48U.S. plans for hundreds of millions of cheap, fast Covid-19 tests